Editas Medicine (EDIT) traded flat 0 % during a 24 hours period ending at 01:24 PM Central Europe on Tuesday 27th. One Editas Medicine stock can currently be bought for about USD 2.4 on popular exchanges. Current supply of Editas Medicine stocks is 154.2 mn. Editas Medicine has a current market capitalization of USD 365.5 mn and approximately USD 3.2 mn worth of Editas Medicine was traded on exchanges in the last 24 hours. Since last month end, Editas Medicine has traded -4.38 % down. Simple moving average of last 200 days is at USD 2.67. The highest price of past 52 weeks was recorded at USD 3.94 on 05/27/2026. 52 weeks low was at USD 1.66 on 02/05/2026.

Here is how related stocks have performed in the past 24 hours:

  • Methode Electronics (MEI) traded up 1.65 % and now trades at USD 12.32. Methode Electronics has a market capitalisation of USD 437 mn.

  • Meshflow Acquisition (MESH) traded flat 0 % and now trades at USD 10.09. Meshflow Acquisition has a market capitalisation of USD 434.9 mn.

  • Idea Acquisition Cl (IACO) traded up 0.2 % and now trades at USD 10.01. Current market capitalisation for Idea Acquisition Cl is USD 437.9 mn.

  • Bank Of Marin /Ca (BMRC) traded up 2.55 % and now trades at USD 27.8. Bank Of Marin /Ca has a market capitalisation of USD 437.9 mn. Bank of Marin Bancorp reported its third‑quarter 2026 results on October 26, 2026. The bank highlighted continued loan growth and an expanding net interest margin, driven by higher loan yields and a lower cost of deposits. Net income rose relative to the prior quarter, while diluted earnings per share increased. Non‑interest income grew, supported by higher service charges on business deposit accounts and dividend income. Expense levels declined modestly, mainly due to lower salaries and benefits. The company declared a quarterly cash dividend of $0.25 per share, payable on November 12, 2026, to shareholders of record as of November 5. Management noted that capital ratios remain well above regulatory thresholds, and the bank’s liquidity position is strong, with ample unencumbered assets and borrowing capacity. An earnings webcast was scheduled for Monday, October 26, at 8:30 a.m. PT.

  • Titan (TWI) traded down -1.78 % and now trades at USD 6.64. Titan has a market capitalisation of USD 438.6 mn.

About Editas Medicine

Editas Medicine, Inc. is a biotechnology company operating in the health care sector with its main aim of translating its transformative genome editing technology into a novel class of human therapeutics for the treatment of diseases.